Navigation Links
Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology
Date:2/18/2009 

    - results from this trial supported entry into Company's current Phase
    III bladder cancer program -

BELLEVILLE, ON, Feb. 18 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that The Journal of Urology has published an article summarizing the Phase II clinical trial results for the Company's proprietary Mycobacterial Cell Wall technology in bladder cancer.

The article, entitled "Intravesical Mycobacterial Cell Wall-DNA Complex in the Treatment of Carcinoma In Situ of the Bladder After Standard Intravesical Therapy has Failed", was co-authored by Drs. Alvaro Morales (Queen's University - Kingston, Ontario, Canada), Kiran Phadke (St.-George Hospital, Kogarah, New South Wales, Australia), and Gary Steinhoff (Vancouver Island Health Authority - Victoria, British Columbia, Canada). The Phase II trial resulted in a complete response rate in the intent-to-treat population of 27.3% at weeks 12 and 26 at a 4 mg dose and a 46.4% response at the same two points in patients receiving an 8 mg dose. Complete response was defined as no evidence of disease as determined by cystoscopy, biopsy and cytology. The product was well tolerated by both dose groups, with 90% of all adverse events being mild to moderate in severity.

"We concluded that Mycobacterial Cell Wall-DNA Complex has shown antineoplastic (anticancer) activity in patients with bladder cancer with less toxicity than that associated with bacillus Calmette-Guerin (BCG) administration," said Dr. Alvaro Morales, Director of the Centre for Advanced Urological Research and Professor in the Department of Urology, Queen's University, Kingston, Ontario, Canada. "Safety concerns exist with BCG because it is a live mycobacterium and its use is associated with a number of local and systemic side effects, as well as the potential for proliferation and systemic dissemination."<
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Bioniche Warrants Expiration Date to be Extended
2. Bioniche Reports Fiscal 2009 Second Quarter
3. Bioniche Invited to Participate in Canadian Beef Value Chain Roundtable
4. Bioniche Named One of the Top 50 Best Small and Medium Employers in Canada
5. Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile
6. Bioniche Reports Fiscal 2009 First Quarter
7. Bioniche Allows Conversion of Portion of Revolving Credit Facility
8. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
9. Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference
10. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
11. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...und with elastography can help differentiate betwe... to a study presented today at the annual meeting ...). , "High-frequency ultrasound with elastograph...kin cancer diagnosis," said lead author Eliot L. S...diology at the University of Maryland School of Me...
(Date:12/1/2009)...d, controlled clinical trial presented today at th...rth America (RSNA) reveal that one in five patient...ly blood to the legs and other parts of the body a...sease. , Peripheral arterial disease (PAD) occu...and other substances, builds up in the arteries, l...
(Date:12/1/2009)... Adolescent obesity is a major public health prob...resulting in 4-5 million overweight youth in the U... 2009 issue of the Journal of the American Dietet... in weight control behaviors, including dietary in...dolescents who lost weight and those who did not i...
(Date:11/30/2009)...ast Fertility is attempting to dispel the notion t...and send patients home pregnant with multiples. W...ent, their priority is health and safety. In addi...hs can put on a country’s healthcare system...., 2009 -- Many patients and doctors in the U.K. wo...
(Date:11/30/2009)...wswire/ -- Results of a randomized, controlled cli...of the Radiological Society of North America (RSNA...or blockage in arteries that supply blood to the l...ant but silent coronary artery disease. ,, Per... a combination of fat, cholesterol and other subst...
Breaking Medicine News(10 mins):Health News:Special ultrasound accurately identifies skin cancer 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:Investigators identify successful weight control strategies for adolescents 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 3Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 3
...who is president-elect of the Chicago Medical Soci...d work with lawmakers in the US on healthcare// re...be paid in cases of medical negligence. Shastr...e 3. Foremost on his agenda, he said, would ...
...eader Pramod Mahajan underwent a minor surgery on ...k after being shot at by his brother//. Doctors...olitician was rushed April 22 after Pravin Mahajan...r and a BJP general secretary, underwent a minor s...
...K has found that care home fees has increased by o... But in the concurrent period basic state pension ...said that the care home fees is bound to jump by a... capital above a certain limit get no help for the...
...(EMEA) has recommended the use of breast cancer dr...cord 27 days review//. A license for the drug is t... Institute of Health and Clinical Excellence in th...l be able to issue national guidance to the NHS on...
...called the Acomplia which the European Medicines A... for weight loss//. After this its shares rose 2.7...proved the drug for weight control. The chemical n...ommittee and FDA to make Acomplia available as an ...
...ultry from UK to prevent the spread of bird flu to...said in statement// as soon as the British ministr...ain of bird flu. This virus is less dangerous ...being spotted on another farm nearby in the easter...
Other Medicine News:Health News:Indian American Doctor Wants Healthcare Reforms 2Health News:Pramod Mahajan Undergoes Third Surgery 2
(Date:11/30/2009)... MT. LAUREL, N.J., Nov. 30 /PRNewswire-FirstCall...rovider of technology-enabled clinical documentati... at the Radiological Society of North America (RSN...r Radiology, the product leverages SpeechQ(TM), th...on application used by thousands of radiologists. ...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Reportli...rt is available in its catalogue: ,, Diabetes ...http://www.reportlinker.com/p0164347/Diabetes-Diag... Diabetes Diagnosis market is driven by a steady i...betes, both in the developed and developing parts ...
(Date:11/30/2009)...EAST ALTON, Ill., Nov. 30 The Simm...ttee dedicated to representing thousands of women ...in), the popular birth control pill manufactured a...S. Judicial Panel on Multidistrict Litigation has ...rol pill lawsuits be consolidated and centralized ...
Breaking Medicine Technology:MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Air Purifier Relief for California Wildfires Victims Suffering from Polluted Air 55961 1Air Purifier Relief for California Wildfires Victims Suffering from Polluted Air 55961 2Air Purifier Relief for California Wildfires Victims Suffering from Polluted Air 55961 3Today 26apos 3Bs Economy Forces Landlords to Get Aggressive Tenants Reap the Rewards 55958 1Today 26apos 3Bs Economy Forces Landlords to Get Aggressive Tenants Reap the Rewards 55958 2Today 26apos 3Bs Economy Forces Landlords to Get Aggressive Tenants Reap the Rewards 55958 3Today 26apos 3Bs Economy Forces Landlords to Get Aggressive Tenants Reap the Rewards 55958 4Study Finds Divorce is Bad for Health Divorce Records Website Comments 55957 1Study Finds Divorce is Bad for Health Divorce Records Website Comments 55957 2
... and 40/25 mg/day and Amlodipine +,Benazepril 5/20...,Hypertension Twenty-Second Annual Scientific Meet...- New data,presented today at the American Society... Meeting (ASH 2007) in Chicago,demonstrated that t...medoxomil/hydrochlorothiazide) was associated with...
...ay 21, 2007 - Medical,professionals seeking to tre...uired gram-negative pneumonia may have a new weapo... candidate being,developed by Nektar Therapeutics ...al evaluating the use of,NKTR-061 (Inhaled Amikaci...hospital-acquired gram-negative pneumonia were,pre...
Other Medicine Technology:Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: